Kailera Therapeutics, Inc. Common Stock KLRA
$16.23
+3.11%
at last close
Analyst Consensus
- Consensus Rating
- Buy (4 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $38.00
- Implied Upside
- +134.1%
- Price Target Range
- $30.00 – $48.00
- Analysts (12 mo)
- 4
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-05-12 | Leerink PartnersDavid Risinger |
Initiates coverage on | Outperform | $36 |
| 2026-05-12 | JefferiesRoger Song |
Initiates coverage on | Buy | $48 |
| 2026-05-12 | Evercore ISI GroupUmer Raffat |
Initiates coverage on | Outperform | — |
| 2026-05-12 | JP MorganHardik Parikh |
Initiates coverage on | Overweight | $30 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $16.23
- Market Cap
- $2.10 billion
- 52-Week Range
- $15.15 – $28.23
- Average Volume
- 619K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.